Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·StrictlyVC·SEPTEMBER 1, 2026
“Ausperbio raised $120M Series C; $360M total since 2024, developing oligonucleotide therapies that suppress hepatitis B virus activity”
Source→02
funding·Axios Pro Rata·SEPTEMBER 1, 2026
“Ausperbio…raised $120m in Series C funding. RA Capital Management led.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.